NO902628L - Produksjon av pyrrolopyrimidiner og mellomprodukter derav. - Google Patents

Produksjon av pyrrolopyrimidiner og mellomprodukter derav.

Info

Publication number
NO902628L
NO902628L NO90902628A NO902628A NO902628L NO 902628 L NO902628 L NO 902628L NO 90902628 A NO90902628 A NO 90902628A NO 902628 A NO902628 A NO 902628A NO 902628 L NO902628 L NO 902628L
Authority
NO
Norway
Prior art keywords
pyrrolopyrimidines
intermediates
production
Prior art date
Application number
NO90902628A
Other languages
English (en)
Other versions
NO177057B (no
NO177057C (no
NO902628D0 (no
Inventor
Hiroshi Akimoto
Takenori Hitaka
Tetsuo Miwa
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of NO902628D0 publication Critical patent/NO902628D0/no
Publication of NO902628L publication Critical patent/NO902628L/no
Publication of NO177057B publication Critical patent/NO177057B/no
Publication of NO177057C publication Critical patent/NO177057C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48—Two nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/50—Three nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO902628A 1989-06-14 1990-06-13 Fremgangsmåte for fremstilling av pyrrolopyrimidiner og mellomprodukter derav NO177057C (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP15091089 1989-06-14
JP24297589 1989-09-18
JP9239190 1990-04-06

Publications (4)

Publication Number Publication Date
NO902628D0 NO902628D0 (no) 1990-06-13
NO902628L true NO902628L (no) 1990-12-17
NO177057B NO177057B (no) 1995-04-03
NO177057C NO177057C (no) 1995-07-12

Family

ID=27307029

Family Applications (1)

Application Number Title Priority Date Filing Date
NO902628A NO177057C (no) 1989-06-14 1990-06-13 Fremgangsmåte for fremstilling av pyrrolopyrimidiner og mellomprodukter derav

Country Status (8)

Country Link
US (2) US5349064A (no)
EP (1) EP0402903A1 (no)
JP (1) JP2983254B2 (no)
KR (1) KR0162492B1 (no)
CN (1) CN1051306C (no)
CA (1) CA2018875C (no)
HU (1) HU205358B (no)
NO (1) NO177057C (no)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0492316A1 (en) * 1990-12-14 1992-07-01 Takeda Chemical Industries, Ltd. Condensed heterocyclic oligoglutamate derivatives, their production and pharmaceutical compositions containing them
EP0530537B1 (en) * 1991-08-12 1997-01-08 Takeda Chemical Industries, Ltd. Condensed pyrimidine derivatives, their production and use as antitumor agents
EP0549291A1 (en) * 1991-12-27 1993-06-30 Takeda Chemical Industries, Ltd. Thymidylate synthase inhibitors
US5502187A (en) * 1992-04-03 1996-03-26 The Upjohn Company Pharmaceutically active bicyclic-heterocyclic amines
US5278307A (en) * 1992-09-25 1994-01-11 Eli Lilly And Company Process for preparing 4-hydroxypyrrolo(2,3-d)pyrimidine based antifolate compounds and intermediates
US5416211A (en) * 1992-09-25 1995-05-16 Eli Lilly And Company Process for preparing 5-substituted pyrrolo-[2,3-d]pyrimidines
HUT70208A (en) * 1992-09-25 1995-09-28 Lilly Co Eli Process for preparing 5-substituted pyrrolo[2,3-d]-pyrimidines
JPH10501532A (ja) * 1994-06-09 1998-02-10 スミスクライン・ビーチャム・コーポレイション エンドセリン受容体拮抗物質
AU4163197A (en) * 1996-08-30 1998-03-19 Eli Lilly And Company Nonclassical pyrrolo{2,3-d}pyrimidine antifolates
US7863444B2 (en) 1997-03-19 2011-01-04 Abbott Laboratories 4-aminopyrrolopyrimidines as kinase inhibitors
CZ301563B6 (cs) * 1997-09-26 2010-04-14 Eli Lilly And Company Zpusob prípravy pyrrolopyrimidinových derivátu
PA8474101A1 (es) * 1998-06-19 2000-09-29 Pfizer Prod Inc Compuestos de pirrolo [2,3-d] pirimidina
US6713474B2 (en) 1998-09-18 2004-03-30 Abbott Gmbh & Co. Kg Pyrrolopyrimidines as therapeutic agents
CA2344262A1 (en) * 1998-09-18 2000-03-30 Basf Aktiengesellschaft 4-aminopyrrolopyrimidines as kinase inhibitors
US7071199B1 (en) 1999-09-17 2006-07-04 Abbott Gmbh & Cco. Kg Kinase inhibitors as therapeutic agents
DK1212327T3 (da) 1999-09-17 2003-12-15 Abbott Gmbh & Co Kg Pyrazolopyrimidiner som terapeutiske midler
TR200400105T4 (tr) 1999-12-10 2004-02-23 Prizer Products Inc. Pirrolo [2,3-d] pirimidin bileşikleri
PL378246A1 (pl) * 2002-11-26 2006-03-20 Pfizer Products Inc. Sposób leczenia odrzucania przeszczepu
DE112008001428T5 (de) * 2007-05-21 2010-04-29 Bol, Stephen J., Muskegon Radfeste Pumpe für sich selbst aufblasende Reifen
PL2384326T3 (pl) 2008-08-20 2014-09-30 Zoetis Services Llc Związki pirolo[2,3-d]pirymidyonowe
US8385364B2 (en) * 2008-09-24 2013-02-26 Nec Laboratories America, Inc. Distributed message-passing based resource allocation in wireless systems

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB812366A (en) * 1955-08-18 1959-04-22 Wellcome Found Improvements in and relating to derivatives of pyrimidine and the preparation thereof
GB8625019D0 (en) * 1986-10-18 1986-11-19 Wellcome Found Compounds
US4871743A (en) * 1988-01-19 1989-10-03 The Trustees Of Princeton University L-glutamic acid derivatives
JP2830008B2 (ja) * 1988-04-01 1998-12-02 武田薬品工業株式会社 縮合ピリミジン誘導体
NO169490C (no) * 1988-03-24 1992-07-01 Takeda Chemical Industries Ltd Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrrolopyrimidinderivater

Also Published As

Publication number Publication date
CN1103401A (zh) 1995-06-07
KR0162492B1 (ko) 1998-12-01
CA2018875C (en) 2000-10-31
JP2983254B2 (ja) 1999-11-29
US5349064A (en) 1994-09-20
JPH049383A (ja) 1992-01-14
EP0402903A1 (en) 1990-12-19
NO177057B (no) 1995-04-03
NO177057C (no) 1995-07-12
HU205358B (en) 1992-04-28
HU903853D0 (en) 1990-11-28
NO902628D0 (no) 1990-06-13
CA2018875A1 (en) 1990-12-14
CN1051306C (zh) 2000-04-12
KR910000736A (ko) 1991-01-30
US5496946A (en) 1996-03-05

Similar Documents

Publication Publication Date Title
NO902628L (no) Produksjon av pyrrolopyrimidiner og mellomprodukter derav.
NO883535L (no) Fremstilling av mikrokrystallinsk boehmitt og derav fremstilte produkter.
NO960552D0 (no) Elektrode og fremstilling av elektroden
PT86196A (pt) Pulseira magnetica aperfeicoada
DE69015990T2 (de) Kompresse und Herstellungsmethode der Kompresse.
IT1219369B (it) Specchio decorativo e procedimento per la sua fabbricazione
IS3718A7 (is) Amínóbenzodiazepines og aðferð til framleiðslu þess
FI883382A (fi) Anvaendning av olefinfoereningar.
FI882265A0 (fi) Foerfarande foer bestaemning av fruktosamin.
NO890661L (no) Fremstilling av antihyperkolesteroltetrazolforbindelser og mellomprodukter derav.
PT87674A (pt) Phenol derivatives their production and use
DK450688D0 (da) Konditioneringsmidler og fremstilling deraf
NO171463C (no) Fremgangsmaate for fremstilling og montering av flytebro e.l.
KR890700427A (ko) 세라믹 제품 및 이의 제조방법
NO881902D0 (no) Sopparoma og fremstilling derav.
DE69002496D1 (de) Herstellung von fluorphenolen.
NO862823L (no) Fremgangsmaate for fremstilling av lenser og liknende.
ES2019251A4 (es) Produccion de alfa-cloro-alfa-oximino-4-hidroxilo acetofenona.
NO880368D0 (no) Acylering og sulfonering av silylketenacetaler.
DE69011565D1 (de) Herstellung von Pre-Kaseinaten und Verwendung.
NO901421D0 (no) Intranasal administrering av fysostigmin og arecolin.
TR24296A (tr) Ferrokrom ueretimine mahsus usul ve tertibat
DE3888733D1 (de) Fluorbenzoate und ihre Herstellung.
NO892652L (no) Derivater av 19-norprogesteron samt fremstilling og bruk derav.
KR890000165U (ko) 귀걸이

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees

Free format text: LAPSED IN DECEMBER 2001